US6228660B1
(en)
|
1908-04-27 |
2001-05-08 |
Conopco Inc. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
US3857931A
(en)
*
|
1971-02-01 |
1974-12-31 |
Hoffmann La Roche |
Latex polymer reagents for diagnostic tests
|
US3852415A
(en)
*
|
1972-10-13 |
1974-12-03 |
Hoffmann La Roche |
Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen
|
US3896217A
(en)
*
|
1973-03-19 |
1975-07-22 |
Summa Corp |
Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
|
US4161515A
(en)
*
|
1973-10-02 |
1979-07-17 |
Syva Company |
Double receptor fluorescent immunoassay
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3959650A
(en)
*
|
1974-08-26 |
1976-05-25 |
Intelcom Rad Tech |
Method for detecting and identifying allergy
|
US4001583A
(en)
*
|
1974-10-04 |
1977-01-04 |
Barrett M James |
Covalently bound biological substances to plastic materials and use in radioassay
|
US4343896A
(en)
*
|
1975-02-01 |
1982-08-10 |
Akzona Incorporated |
Method and test pack for the demonstration and determination of an antigen or antibody
|
US4133639A
(en)
*
|
1975-02-27 |
1979-01-09 |
International Diagnostic Technology, Inc. |
Test article including a covalently attached diagnostic reagent and method
|
US4041146A
(en)
*
|
1975-05-01 |
1977-08-09 |
General Electric Company |
Method for detection of biological particles
|
US4201763A
(en)
*
|
1975-10-09 |
1980-05-06 |
Bio-Rad Laboratories, Inc. |
Solid phase immunofluorescent assay method
|
US4036946A
(en)
*
|
1975-10-20 |
1977-07-19 |
Marcos Kleinerman |
Immunofluorometric method for measuring minute quantities of antigens, antibodies and other substances
|
US4144031A
(en)
*
|
1976-04-19 |
1979-03-13 |
International Radioimmune Systems, Inc. |
Cell test for detecting human chorionic gonadotropin
|
US4067959A
(en)
*
|
1976-05-10 |
1978-01-10 |
International Diagnostic Technology, Inc. |
Indirect solid surface test for antigens or antibodies
|
US4090850A
(en)
*
|
1976-11-01 |
1978-05-23 |
E. R. Squibb & Sons, Inc. |
Apparatus for use in radioimmunoassays
|
US4166844A
(en)
*
|
1977-04-18 |
1979-09-04 |
E. R. Squibb & Sons, Inc. |
Solid phase separation technique for use in radioimmunoassays
|
US4160016A
(en)
*
|
1977-05-16 |
1979-07-03 |
Syva Company |
Receptor fluorescent immunoassay
|
FR2445966A1
(fr)
*
|
1978-01-26 |
1980-08-01 |
Miles Lab |
Procede de normalisation d'un constituant marque
|
DE2900546A1
(de)
*
|
1978-01-26 |
1979-08-30 |
Miles Lab |
Spezifische bindungstest-verfahren
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4207075A
(en)
*
|
1978-08-08 |
1980-06-10 |
Liburdy Robert P |
Rabbit immunoglobulin-N-(3-pyrene)-maleimide conjugate for fluorescent immunoassay
|
US4228127A
(en)
*
|
1978-10-06 |
1980-10-14 |
International Radioimmune Systems, Inc. |
Kit for detecting human chorionic gonadotropin
|
FR2438844A2
(fr)
*
|
1978-10-12 |
1980-05-09 |
Int Diagnostic Tech |
Procede et appareil d'analyse quantitative par fluorometrie
|
US4238195A
(en)
*
|
1979-01-18 |
1980-12-09 |
Miles Laboratories, Inc. |
Fluorescer-labeled specific binding assays
|
US4256834A
(en)
*
|
1979-04-09 |
1981-03-17 |
Syva Company |
Fluorescent scavenger particle immunoassay
|
WO1980002201A1
(fr)
*
|
1979-04-09 |
1980-10-16 |
Minnesota Mining & Mfg |
Procede de determination de classes d'anticorps d'antigenes specifiques
|
US4236893A
(en)
*
|
1979-04-09 |
1980-12-02 |
Minnesota Mining And Manufacturing Company |
Method for the assay of classes of antigen-specific antibodies
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4254096A
(en)
*
|
1979-10-04 |
1981-03-03 |
Bio-Rad Laboratories, Inc. |
Reagent combination for solid phase immunofluorescent assay
|
US4373932A
(en)
*
|
1980-01-11 |
1983-02-15 |
Akzona Incorporated |
Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays
|
US4331650A
(en)
*
|
1980-07-18 |
1982-05-25 |
Science Research Center, Inc. |
Identification of reagins in the blood serum of allergen sensitized vertebrates
|
US4357142A
(en)
*
|
1980-07-18 |
1982-11-02 |
Akzona Incorporated |
Glass support coated with synthetic polymer for bioprocess
|
US4486540A
(en)
*
|
1980-07-18 |
1984-12-04 |
Science Research Center, Inc. |
Identification of reagins in the blood serum of allergen sensitized vertebrates
|
US4696907A
(en)
*
|
1980-07-18 |
1987-09-29 |
Science Research Center, Inc. |
Identification of reagins in the blood serum of allergen sensitized vertebrates
|
US4629706A
(en)
*
|
1982-02-01 |
1986-12-16 |
Miles Laboratories, Inc. |
Method for determining allergic sensitivity
|
US4452773A
(en)
*
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US4621063A
(en)
*
|
1982-10-12 |
1986-11-04 |
The Center For Immunological Studies |
Methods for the detection and quantitation of immunological substances
|
EP0106324A2
(fr)
*
|
1982-10-13 |
1984-04-25 |
Minnesota Mining And Manufacturing Company |
Essai fluorométrique de réactions allergiques et réactifs appropriés
|
EP0106324A3
(en)
*
|
1982-10-13 |
1986-09-17 |
Minnesota Mining And Manufacturing Company |
Fluorometric assay of allergic reactions and reagents therefor
|
US4845027A
(en)
*
|
1982-10-13 |
1989-07-04 |
Minnesota Mining And Manufacturing Company |
Fluorometric assay of allergic reactions
|
US4528267A
(en)
*
|
1982-11-26 |
1985-07-09 |
Axionics, Inc. |
Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts
|
US4849337A
(en)
*
|
1983-01-31 |
1989-07-18 |
Minnesota Mining And Manufacturing Company |
Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
|
EP0131546A3
(en)
*
|
1983-05-13 |
1987-02-04 |
Laboratorio Farmaceutico Lofarma S.R.L. |
Method for stably binding antigens and allergens to solid supports and supports obtained
|
EP0131546A2
(fr)
*
|
1983-05-13 |
1985-01-16 |
LABORATORIO FARMACEUTICO LOFARMA s.r.l. |
Méthode pour lier d'une manière stable des antigènes et des allergènes à polystyrène et supports ainsi obtenus
|
FR2547057A1
(fr)
*
|
1983-05-13 |
1984-12-07 |
Lofarma Farma Lab |
Procede pour fixer d'une facon stable des antigenes et des allergenes sur des supports solides, et supports destines a cet usage
|
WO1985002262A1
(fr)
*
|
1983-11-10 |
1985-05-23 |
Ventrex Laboratories, Inc. |
Matrices portant de multiples allergenes utiles pour un tamisage qualitatif d'allergies
|
US4891311A
(en)
*
|
1984-02-03 |
1990-01-02 |
Abbott Laboratories |
Stabilized enzyme conjugate composition
|
US4677067A
(en)
*
|
1984-06-22 |
1987-06-30 |
Bio-Magnetech Corporation |
Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like
|
US4670383A
(en)
*
|
1984-09-13 |
1987-06-02 |
Boehringer Mannheim Gmbh |
Immune-chemical measurement process for haptens and proteins
|
US4935339A
(en)
*
|
1985-05-07 |
1990-06-19 |
Nichols Institute Diagnostics |
Delayed solid phase immunologic assay
|
US4738932A
(en)
*
|
1985-12-03 |
1988-04-19 |
Advanced Polymer Systems, Inc. |
Reaginic test for syphilis
|
WO1987003692A1
(fr)
*
|
1985-12-03 |
1987-06-18 |
Advanced Polymer Systems, Inc. |
Test reaginique pour la syphilis
|
EP0245926A2
(fr)
*
|
1986-05-12 |
1987-11-19 |
Diagnostic Products Corporation |
Procédé pour déterminer les antigènes ou les anticorps dans les fluides biologiques utilisant des antigènes ou des anticorps marqués avec un ligand
|
EP0245926A3
(en)
*
|
1986-05-12 |
1988-05-25 |
Diagnostic Products Corporation |
Method of measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
|
US5156952A
(en)
*
|
1986-11-07 |
1992-10-20 |
Syntex (U.S.A.) Inc. |
Qualitative immunochromatographic method and device
|
US5030558A
(en)
*
|
1986-11-07 |
1991-07-09 |
Syntex (U.S.A.) Inc. |
Qualitative immunochromatographic method and device
|
US5232835A
(en)
*
|
1986-11-07 |
1993-08-03 |
Syntex (U.S.A.) Inc. |
Qualitative immunochromatographic method and device
|
US7109042B2
(en)
|
1987-04-27 |
2006-09-19 |
Inverness Medical Switzerland Gmbh |
Assays
|
US5622871A
(en)
*
|
1987-04-27 |
1997-04-22 |
Unilever Patent Holdings B.V. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
US6187598B1
(en)
|
1987-04-27 |
2001-02-13 |
Conopco Inc. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
US6818455B2
(en)
|
1987-04-27 |
2004-11-16 |
Inverness Medical Switzerland Gmbh |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
US5656503A
(en)
*
|
1987-04-27 |
1997-08-12 |
Unilever Patent Holdings B.V. |
Test device for detecting analytes in biological samples
|
US5098846A
(en)
*
|
1987-05-27 |
1992-03-24 |
Mclean Hospital |
Solid phase protein assay by solid phase free site titration
|
US5132209A
(en)
*
|
1987-09-14 |
1992-07-21 |
Vanderbeeken Yves E |
Process for testing for maternal-fetal immunoincompatibility in pregnant women
|
US4891321A
(en)
*
|
1987-10-21 |
1990-01-02 |
Hubscher Thomas T |
Apparatus for performing determinations of immune reactants in biological fluids
|
US5494830A
(en)
*
|
1987-10-21 |
1996-02-27 |
Hubscher; Thomas T. |
Methods for performing determinations of immune reactants in biological fluids
|
US7238537B2
(en)
|
1989-02-17 |
2007-07-03 |
Inverness Medical Switzerland Gmbh |
Assays
|
US7384796B2
(en)
|
1989-02-17 |
2008-06-10 |
Inverness Medical Switzerland Gmbh |
Assays
|
US7407813B2
(en)
|
1989-02-17 |
2008-08-05 |
Inverness Medical Switzerland Gmbh |
Assays
|
US6352862B1
(en)
|
1989-02-17 |
2002-03-05 |
Unilever Patent Holdings B.V. |
Analytical test device for imuno assays and methods of using same
|
US20030143755A1
(en)
*
|
1989-02-17 |
2003-07-31 |
Davis Paul James |
Assays
|
EP0451800A1
(fr)
*
|
1990-04-13 |
1991-10-16 |
Abbott Laboratories |
Attachement d'allergènes à une phase solide
|
US5091318A
(en)
*
|
1990-04-13 |
1992-02-25 |
Abbott Laboratories |
Binding of allergens to a solid phase
|
US5429929A
(en)
*
|
1991-04-19 |
1995-07-04 |
The Trustees Of Columbia University In The City Of New York |
Method for detecting antibodies to a neuroblastoma antigen in mental illness
|
US5877028A
(en)
*
|
1991-05-29 |
1999-03-02 |
Smithkline Diagnostics, Inc. |
Immunochromatographic assay device
|
US5998220A
(en)
*
|
1991-05-29 |
1999-12-07 |
Beckman Coulter, Inc. |
Opposable-element assay devices, kits, and methods employing them
|
US6017767A
(en)
*
|
1991-05-29 |
2000-01-25 |
Beckman Coulter, Inc. |
Assay device
|
US6168956B1
(en)
|
1991-05-29 |
2001-01-02 |
Beckman Coulter, Inc. |
Multiple component chromatographic assay device
|
US5244788A
(en)
*
|
1992-07-01 |
1993-09-14 |
Hubscher Thomas T |
Method and apparatus for performing determinations of immune rectants in biological fluids
|
US5558869A
(en)
*
|
1992-12-30 |
1996-09-24 |
University Of Arkansas |
Major peanut allergen ara h II
|
US5973121A
(en)
*
|
1992-12-30 |
1999-10-26 |
University Of Arkansas |
Immunoassay for peanut allergen
|
US6441142B1
(en)
|
1992-12-30 |
2002-08-27 |
University Of Arkansas |
Immunoassay for peanut allergen
|
US5561049A
(en)
*
|
1994-09-21 |
1996-10-01 |
Behringwerke Ag |
Method for detecting antibodies
|
US5736343A
(en)
*
|
1995-08-18 |
1998-04-07 |
Landry; Donald |
Detection of organic compounds through regulation of antibody-catalyzed reactions
|
US20030202980A1
(en)
*
|
1995-12-29 |
2003-10-30 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
US6835824B1
(en)
|
1995-12-29 |
2004-12-28 |
University Of Arkansas |
Peanut allergens and methods
|
US20030049237A1
(en)
*
|
1996-09-23 |
2003-03-13 |
Bannon Gary A. |
Methods and reagents for decreasing clinical reaction to allergy
|
US7485708B2
(en)
|
1996-09-23 |
2009-02-03 |
University Of Arkansas |
Nucleic acids encoding ara h 3 polypeptides
|
US5879951A
(en)
*
|
1997-01-29 |
1999-03-09 |
Smithkline Diagnostics, Inc. |
Opposable-element assay device employing unidirectional flow
|
US5939252A
(en)
*
|
1997-05-09 |
1999-08-17 |
Lennon; Donald J. |
Detachable-element assay device
|
EP2033970A2
(fr)
|
1997-10-29 |
2009-03-11 |
Genentech, Inc. |
Gènes inductibles WNT-1
|
EP2014770A2
(fr)
|
1997-10-29 |
2009-01-14 |
Genentech, Inc. |
Polypeptide secrété à induction par WNT-1 WISP-2
|
US7405084B1
(en)
*
|
1997-12-30 |
2008-07-29 |
Phadia Ab |
Analytical method using particles and test kit for performing the method
|
US7879977B2
(en)
|
1998-01-31 |
2011-02-01 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
US6271044B1
(en)
|
1998-05-06 |
2001-08-07 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Method and kit for detecting an analyte
|
US6855508B2
(en)
|
1999-11-16 |
2005-02-15 |
Genentech, Inc. |
ELISA for VEGF
|
US7541160B2
(en)
|
1999-11-16 |
2009-06-02 |
David Tai Wai Fei |
ELISA for VEGF
|
US20070202558A1
(en)
*
|
1999-11-16 |
2007-08-30 |
Genentech, Inc. |
ELISA for VEGF
|
US20050233387A1
(en)
*
|
1999-12-23 |
2005-10-20 |
Genentech, Inc. |
Assay method
|
US20060234306A1
(en)
*
|
1999-12-23 |
2006-10-19 |
Genentech, Inc. |
Assay method
|
US20030129675A1
(en)
*
|
1999-12-23 |
2003-07-10 |
Genentech, Inc. |
Assay method
|
US20050063994A1
(en)
*
|
2000-04-06 |
2005-03-24 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
US20100166802A1
(en)
*
|
2000-04-06 |
2010-07-01 |
Caplan Michael J |
Methods and reagents for decreasing clinical reaction to allergy
|
US20040234548A1
(en)
*
|
2000-04-06 |
2004-11-25 |
Caplan Michael J. |
Microbial delivery system
|
US8815251B2
(en)
|
2000-04-06 |
2014-08-26 |
Allertein Therapeutics, Llc |
Microbial delivery system
|
US8153414B2
(en)
|
2000-04-06 |
2012-04-10 |
Allertein Therapeutics, Llc |
Microbial delivery system
|
US20040208894A1
(en)
*
|
2000-04-06 |
2004-10-21 |
Caplan Michael J |
Microbial delivery system
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
US20080139406A1
(en)
*
|
2000-10-03 |
2008-06-12 |
Reinhard Hiller |
Allergen-Microarray Assay
|
WO2002029415A1
(fr)
*
|
2000-10-03 |
2002-04-11 |
Vbc-Genomics Bioscience Research Gmbh |
Test de jeu ordonne de microechantillons d'allergenes
|
EP1195606A1
(fr)
*
|
2000-10-03 |
2002-04-10 |
VBC-Genomics Forschungsges.m.b.H. |
Procédé de dosage d'allergènes avec un micro-réseau
|
CN1325919C
(zh)
*
|
2000-10-03 |
2007-07-11 |
Vbc-基因组生物科学研究股份公司 |
过敏原微阵列分析
|
US20050101031A1
(en)
*
|
2000-10-03 |
2005-05-12 |
Reinhard Hiller |
Allergen-microarray assay
|
US20020168782A1
(en)
*
|
2001-01-03 |
2002-11-14 |
Mccall Catherine A. |
Detection of allergen-specific IgE
|
US20050214866A1
(en)
*
|
2001-01-03 |
2005-09-29 |
Mccall Catherine A |
Detection of allergen-specific IgE
|
EP2065467A2
(fr)
|
2001-02-22 |
2009-06-03 |
Genentech, Inc. |
Anticorps anti-interferon-alpha
|
EP2292301A2
(fr)
|
2001-02-22 |
2011-03-09 |
Genentech, Inc. |
Anticorps anti-interférons-alpha
|
US9995744B2
(en)
|
2002-07-29 |
2018-06-12 |
Abbott Point Of Care Inc. |
Multiple hybrid immunoassay
|
US10641767B2
(en)
|
2002-07-29 |
2020-05-05 |
Abbott Point Of Care Inc. |
Multiple hybrid immunoassay
|
US9267939B2
(en)
|
2002-07-29 |
2016-02-23 |
Abbott Point Of Care Inc. |
Multiple hybrid immunoassay
|
US20060099662A1
(en)
*
|
2004-04-16 |
2006-05-11 |
Genentech, Inc. |
Assay for antibodies
|
US20070015228A1
(en)
*
|
2004-04-16 |
2007-01-18 |
Genentech, Inc. |
Assay for Antibodies
|
US20080176257A9
(en)
*
|
2004-04-16 |
2008-07-24 |
Genentech, Inc. |
Assay for Antibodies
|
US20050255527A1
(en)
*
|
2004-05-15 |
2005-11-17 |
Genentech, Inc. |
Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
|
US7514223B2
(en)
|
2004-05-15 |
2009-04-07 |
Genentech, Inc. |
Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
|
US20060182716A1
(en)
*
|
2004-08-09 |
2006-08-17 |
Jin Hong |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US20060204473A1
(en)
*
|
2004-08-09 |
2006-09-14 |
Blatt Lawrence M |
Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
|
US20100099851A1
(en)
*
|
2004-08-09 |
2010-04-22 |
Alios Biopharma, Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
EP2290087A2
(fr)
|
2004-12-22 |
2011-03-02 |
Genentech, Inc. |
Méthode de production de protéines multi-membranaires
|
EP2290086A2
(fr)
|
2004-12-22 |
2011-03-02 |
Genentech, Inc. |
Méthode de production de protéines multi-membranaires
|
EP2290088A1
(fr)
|
2004-12-22 |
2011-03-02 |
Genentech, Inc. |
Méthode de production de protéines multi-membranaires
|
US20070161089A1
(en)
*
|
2005-11-08 |
2007-07-12 |
Genentech, Inc. |
Method of Producing Pan-Specific Antibodies
|
EP2402373A2
(fr)
|
2006-01-05 |
2012-01-04 |
Genentech, Inc. |
Anticorps anti-EphB4 et procédés d'utilisation associés
|
EP3156418A1
(fr)
|
2006-01-05 |
2017-04-19 |
Genentech, Inc. |
Anticorps anti-ephb4 et procédés d'utilisation associés
|
EP2093235A1
(fr)
|
2006-02-08 |
2009-08-26 |
Alios Biopharma Inc. |
Variantes hyperglycosylées du interferon alfacon-1
|
EP2468772A2
(fr)
|
2006-03-16 |
2012-06-27 |
Genentech, Inc. |
Anticorps pour EGFL7 et leurs procédés d'utilisation
|
EP2447282A2
(fr)
|
2006-05-30 |
2012-05-02 |
Genentech, Inc. |
Anti-CD22 Anticorps, immuno-conjugués et utilisations associées
|
EP2446904A2
(fr)
|
2006-05-30 |
2012-05-02 |
Genentech, Inc. |
Anti-CD22 anticorps, immuno-conjugués et utilisations associées
|
EP3103812A1
(fr)
|
2006-10-04 |
2016-12-14 |
Genentech, Inc. |
Elisa pour vegf
|
EP2457929A1
(fr)
|
2006-10-04 |
2012-05-30 |
Genentech, Inc. |
ELISA pour VEGF
|
WO2008060777A2
(fr)
|
2006-10-04 |
2008-05-22 |
Genentech, Inc. |
Utilisation de la technique elisa pour rechercher vegf
|
EP2845866A1
(fr)
|
2006-10-27 |
2015-03-11 |
Genentech, Inc. |
Anticorps et immuno-conjugués et utilisations associées
|
US20080171344A1
(en)
*
|
2006-12-22 |
2008-07-17 |
Kapsner Kenneth P |
Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
|
WO2008150525A1
(fr)
|
2007-06-04 |
2008-12-11 |
Genentech, Inc. |
Anticorps anti-notch 1 spécifiques à nrr et ses procédés d'utilisation
|
EP2474557A2
(fr)
|
2007-07-16 |
2012-07-11 |
Genentech, Inc. |
Anticorps anti-CD79b, immuno-conjugués et procédés d'utilisation
|
WO2009012256A1
(fr)
|
2007-07-16 |
2009-01-22 |
Genentech, Inc. |
Anticorps anti-cd79b humanisés, immunoconjugués, et procédés d'utilisation
|
EP2641618A2
(fr)
|
2007-07-16 |
2013-09-25 |
Genentech, Inc. |
Anticorps anti-CD79B humanisés et immuno-conjugués et procédés dýutilisation
|
EP2502937A2
(fr)
|
2007-07-16 |
2012-09-26 |
Genentech, Inc. |
Anticorps anti-CD 79b, immuno-conjugués et procédés d'utilisation
|
EP3173425A1
(fr)
|
2007-11-30 |
2017-05-31 |
Genentech, Inc. |
Anticorps anti-vegf
|
EP2851372A1
(fr)
|
2007-11-30 |
2015-03-25 |
Genentech, Inc. |
Anticorps anti-VEGF
|
EP2657253A2
(fr)
|
2008-01-31 |
2013-10-30 |
Genentech, Inc. |
Anticorps anti-CD79b et immuno-conjugués et procédés d'utilisation
|
US10342812B2
(en)
|
2008-04-08 |
2019-07-09 |
B&H Biotechnologies, Llc |
Glycan-based drugs, therapies and biomarkers
|
US20110085981A1
(en)
*
|
2008-04-08 |
2011-04-14 |
Huiru Wang |
Glycan-based drugs, therapies and biomarkers
|
US11285166B2
(en)
|
2008-04-08 |
2022-03-29 |
B&H Biotechnologies, Llc |
Glycan-based drugs, therapies and biomarkers
|
US9119866B2
(en)
*
|
2008-04-08 |
2015-09-01 |
Huiru Wang |
Glycan-based drugs, therapies and biomarkers
|
WO2010028277A1
(fr)
|
2008-09-04 |
2010-03-11 |
Beckman Coulter, Inc. |
Activation de la pan-kinase et évaluation de voies de signalisation
|
WO2010120561A1
(fr)
|
2009-04-01 |
2010-10-21 |
Genentech, Inc. |
Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
|
WO2011028950A1
(fr)
|
2009-09-02 |
2011-03-10 |
Genentech, Inc. |
Mutant smoothened et ses méthodes d'utilisation
|
US20110183363A1
(en)
*
|
2009-10-26 |
2011-07-28 |
Saloumeh Fischer |
Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
|
US9315583B2
(en)
|
2009-10-26 |
2016-04-19 |
Genentech, Inc. |
Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
|
WO2011071577A1
(fr)
|
2009-12-11 |
2011-06-16 |
Genentech, Inc. |
Anticorps anti-vegf-c et leurs procédés d'utilisation
|
WO2011079185A1
(fr)
|
2009-12-23 |
2011-06-30 |
Genentech, Inc. |
Anticorps anti-bv8 et leurs utilisations
|
EP3196212A1
(fr)
|
2010-02-24 |
2017-07-26 |
Immunogen, Inc. |
Anticorps de récepteur 1 de folate et immunoconjugués et leurs utilisations
|
EP3620467A1
(fr)
|
2010-03-12 |
2020-03-11 |
Debiopharm International SA |
Molécules de liaison cd37 et immunoconjugués correspondants
|
WO2011153346A1
(fr)
|
2010-06-03 |
2011-12-08 |
Genentech, Inc. |
Imagerie par immuno-tep d'anticorps et d'immunoconjugués et utilisations correspondantes
|
US8771966B2
(en)
|
2010-06-03 |
2014-07-08 |
Genentech, Inc. |
Immuno-PET imaging of antibodies and immunoconjugates and uses therefor
|
WO2012019024A2
(fr)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Molécules se liant à her3 et leurs immunoconjugués
|
WO2012030738A2
(fr)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Profils complexes d'activation de phosphoprotéines
|
WO2012047968A2
(fr)
|
2010-10-05 |
2012-04-12 |
Genentech, Inc. |
Mutant smoothened et ses procédés d'utilisation
|
WO2012092539A2
(fr)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Anticorps contre dll4 et leurs utilisations
|
WO2012149320A1
(fr)
|
2011-04-29 |
2012-11-01 |
Bristol-Myers Squibb Company |
Schémas posologiques à doses progressivement croissantes d'anticorps anti-ip-10
|
US8609355B2
(en)
|
2011-07-26 |
2013-12-17 |
Indicator Systems International, Inc. |
Assays for the detection of microbes
|
WO2013078377A1
(fr)
|
2011-11-23 |
2013-05-30 |
Igenica, Inc. |
Anticorps anti-cd98 et leurs procédés d'utilisation
|
WO2013142796A2
(fr)
|
2012-03-23 |
2013-09-26 |
Bristol-Myers Squibb Company |
Procédés de traitements au moyen d'anticorps anti-ctla4
|
US9139659B2
(en)
*
|
2012-03-28 |
2015-09-22 |
Genentech, Inc. |
Idiotypic antibodies and uses thereof
|
US20130266973A1
(en)
*
|
2012-03-28 |
2013-10-10 |
Genentech, Inc. |
Idiotypic antibodies and uses thereof
|
WO2013148373A1
(fr)
|
2012-03-28 |
2013-10-03 |
Genentech, Inc. |
Anticorps idiotypiques anti-hcmv et leurs utilisations
|
US10513556B2
(en)
|
2012-05-07 |
2019-12-24 |
Amgen Inc. |
Anti-erythropoietin antibodies
|
US9441039B2
(en)
|
2012-05-07 |
2016-09-13 |
Amgen Inc. |
Anti-erythropoietin antibodies
|
WO2013169734A1
(fr)
|
2012-05-07 |
2013-11-14 |
Amgen Inc. |
Anticorps anti-érythropoïétine
|
US10919975B2
(en)
|
2012-06-27 |
2021-02-16 |
Amgen Inc. |
Anti-mesothelin binding proteins
|
US11866508B2
(en)
|
2012-06-27 |
2024-01-09 |
Amgen Inc. |
Anti-mesothelin binding proteins
|
US10100121B2
(en)
|
2012-06-27 |
2018-10-16 |
Amgen Inc. |
Anti-mesothelin binding proteins
|
WO2014059028A1
(fr)
|
2012-10-09 |
2014-04-17 |
Igenica, Inc. |
Anticorps anti-c16orf54 et leurs méthodes d'utilisation
|
WO2014122166A1
(fr)
|
2013-02-06 |
2014-08-14 |
Pieris Ag |
Nouveaux dosages de lipocaline-mutéine pour mesurer la concentration en hepdicine
|
EP3888671A2
(fr)
|
2013-03-11 |
2021-10-06 |
Amgen Inc. |
Formulations protéiques
|
WO2014160160A2
(fr)
|
2013-03-13 |
2014-10-02 |
Novartis Ag |
Conjugués anticorps-médicaments
|
EP3514178A1
(fr)
|
2013-03-15 |
2019-07-24 |
Novartis AG |
Conjugués anticorps-médicament
|
US10151754B2
(en)
|
2014-01-17 |
2018-12-11 |
Minomic International Ltd. |
Cell surface prostate cancer antigen for diagnosis
|
EP3738981A1
(fr)
|
2014-01-24 |
2020-11-18 |
NGM Biopharmaceuticals, Inc. |
Anticorps liant beta-klotho 2 et leurs procédés d'utilisation
|
WO2015120075A2
(fr)
|
2014-02-04 |
2015-08-13 |
Genentech, Inc. |
Mutant smoothened et méthodes d'utilisation de celui-ci
|
WO2016020791A1
(fr)
|
2014-08-05 |
2016-02-11 |
Novartis Ag |
Conjugués anticorps ckit-médicament
|
WO2016024195A1
(fr)
|
2014-08-12 |
2016-02-18 |
Novartis Ag |
Conjugués médicament-anticorps anti-cdh6
|
WO2016075670A1
(fr)
|
2014-11-14 |
2016-05-19 |
Novartis Ag |
Conjugués anticorps-médicament
|
WO2016126972A1
(fr)
|
2015-02-04 |
2016-08-11 |
Genentech, Inc. |
Mutant smoothened et méthodes d'utilisation de celui-ci
|
WO2016149537A1
(fr)
|
2015-03-17 |
2016-09-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Protéine de prion du campagnol roussâtre utilisée comme substrat à large spectre pour détection et discrimination de souches de prions basées sur une conversion induite par agitation en temps réel (rt-quic)
|
WO2016203432A1
(fr)
|
2015-06-17 |
2016-12-22 |
Novartis Ag |
Conjugués anticorps-médicament
|
WO2017040342A1
(fr)
|
2015-08-28 |
2017-03-09 |
Genentech, Inc. |
Anticorps anti-hypusine et leurs utilisations
|
EP3932953A1
(fr)
|
2015-08-28 |
2022-01-05 |
F. Hoffmann-La Roche AG |
Anticorps anti-hypusine et leurs utilisations
|
WO2017046676A1
(fr)
|
2015-09-16 |
2017-03-23 |
Novartis Ag |
Anticorps de neutralisation du virus du polyome
|
US10358497B2
(en)
|
2015-09-29 |
2019-07-23 |
Amgen Inc. |
Methods of treating cardiovascular disease with an ASGR inhibitor
|
US11066472B2
(en)
|
2015-09-29 |
2021-07-20 |
Amgen Inc. |
Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof
|
US10816549B2
(en)
|
2015-12-15 |
2020-10-27 |
Case Western Reserve University |
Epithelial cancer evaluation using beta defensin
|
WO2017106527A1
(fr)
|
2015-12-15 |
2017-06-22 |
Case Western Reserve University |
Évaluation de cancer épithélial à l'aide la bêta-défensine
|
WO2017136558A1
(fr)
|
2016-02-04 |
2017-08-10 |
Curis, Inc. |
Mutant smoothened et méthodes d'utilisation dudit mutant
|
WO2018136553A1
(fr)
|
2017-01-18 |
2018-07-26 |
Genentech, Inc. |
Anticorps idiotypiques dirigés contre des anticorps anti-pd-l1 et leurs utilisations
|
US11279762B2
(en)
|
2017-01-18 |
2022-03-22 |
Genentech, Inc. |
Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
|
WO2018142322A1
(fr)
|
2017-02-03 |
2018-08-09 |
Novartis Ag |
Conjugués anticorps-médicament anti-ccr7
|
WO2019106578A2
(fr)
|
2017-12-01 |
2019-06-06 |
Novartis Ag |
Anticorps neutralisant les polyomavirus
|
US11932681B2
(en)
|
2018-05-31 |
2024-03-19 |
Novartis Ag |
Hepatitis B antibodies
|
WO2019229699A1
(fr)
|
2018-05-31 |
2019-12-05 |
Novartis Ag |
Anticorps contre l'hépatite b
|
WO2020053742A2
(fr)
|
2018-09-10 |
2020-03-19 |
Novartis Ag |
Anticorps peptidiques anti-hla-vhb
|
WO2020081493A1
(fr)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Protéines de liaison pd-l1
|
WO2020128863A1
(fr)
|
2018-12-19 |
2020-06-25 |
Novartis Ag |
Anticorps anti-tnf-alpha
|
WO2020128612A2
(fr)
|
2018-12-21 |
2020-06-25 |
Novartis Ag |
Anticorps dirigés contre pmel17 et conjugués de ces derniers
|
WO2021220199A1
(fr)
|
2020-04-30 |
2021-11-04 |
Novartis Ag |
Conjugués anticorps-médicament ccr7 pour le traitement du cancer
|
WO2021222333A1
(fr)
|
2020-04-30 |
2021-11-04 |
Genentech, Inc. |
Anticorps spécifiques de kras et leurs utilisations
|
WO2021247457A2
(fr)
|
2020-06-01 |
2021-12-09 |
Genentech, Inc. |
Procédés de préparation de vésicules extracellules et leurs utilisations
|
WO2022081436A1
(fr)
|
2020-10-15 |
2022-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticorps spécifique du domaine de liaison du récepteur du sars-cov-2 et procédés thérapeutiques
|
WO2022087274A1
(fr)
|
2020-10-21 |
2022-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticorps qui neutralisent l'activité de l'interféron de type i (ifn)
|
WO2022178255A2
(fr)
|
2021-02-19 |
2022-08-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticorps à domaine unique qui neutralisent le sars-cov-2
|
WO2022266659A1
(fr)
|
2021-06-17 |
2022-12-22 |
Genentech, Inc. |
Anticorps anti-ubiquitination et méthodes d'utilisation
|